Quantification of SAA1 and SAA2 in lung cancer plasma using the isotype-specific PRM assays

Verification of the Biomarker Candidates for Non-small-cell Lung Cancer Using a Targeted Proteomics Approach

(2015) Yeoun Jin Kim et al.   JOURNAL OF PROTEOME RESEARCH

Advances in multiplexed MRM-based protein biomarker quantitation toward clinical utility

(2013) Andrew J. Percy et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Measurement of Thyroglobulin by Liquid Chromatography-Tandem Mass Spectrometry in Serum and Plasma in the Presence of Antithyroglobulin Autoantibodies

(2013) M. M. Kushnir et al.   CLINICAL CHEMISTRY

Technical considerations for large-scale parallel reaction monitoring analysis

(2013) Sebastien Gallien et al.   Journal of Proteomics

Targeted proteomics strategy applied to biomarker evaluation

(2013) Yeoun Jin Kim et al.   Proteomics Clinical Applications

Large-scale isotype-specific quantification of Serum amyloid A 1/2 by multiple reaction monitoring in crude sera

(2012) Hye-Jin Sung et al.   Journal of Proteomics

SAA1 is over-expressed in plasma of non small cell lung cancer patients with poor outcome after treatment with epidermal growth factor receptor tyrosine-kinase inhibitors

(2012) Enrico Milan et al.   Journal of Proteomics

Selectivity of LC-MS/MS analysis: Implication for proteomics experiments

(2012) Sebastien Gallien et al.   Journal of Proteomics

Prognostic and Predictive Role of the VeriStrat Plasma Test in Patients with Advanced Non–Small-Cell Lung Cancer Treated with Erlotinib or Placebo in the NCIC Clinical Trials Group BR.21 Trial

(2012) David P. Carbone et al.   Journal of Thoracic Oncology

Targeted Proteomic Quantification on Quadrupole-Orbitrap Mass Spectrometer

(2012) Sebastien Gallien et al.   MOLECULAR & CELLULAR PROTEOMICS

Characterization of a serum protein pattern from NSCLC patients treated with Gefitinib

(2011) V.M. Garrisi et al.   CLINICAL BIOCHEMISTRY

Selected reaction monitoring applied to proteomics

(2011) Sebastien Gallien et al.   JOURNAL OF MASS SPECTROMETRY

Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer

(2010) S L Wood et al.   BRITISH JOURNAL OF CANCER

Serum amyloid A is elevated in the serum of lung cancer patients with poor prognosis

(2010) W C S Cho et al.   BRITISH JOURNAL OF CANCER

Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk

(2010) Mattia Cremona et al.   CANCER

Identification and Validation of SAA as a Potential Lung Cancer Biomarker and its Involvement in Metastatic Pathogenesis of Lung Cancer

(2010) Hye-Jin Sung et al.   JOURNAL OF PROTEOME RESEARCH

A novel axis of innate immunity in cancer

(2010) Stephen R Mattarollo et al.   NATURE IMMUNOLOGY

Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A

(2010) Carmela De Santo et al.   NATURE IMMUNOLOGY

Inflammatory Protein Serum Amyloid A1 Marks a Subset of Conventional Renal Cell Carcinomas with Fatal Outcome

(2009) Claudia Paret et al.   EUROPEAN UROLOGY

High-throughput generation of selected reaction-monitoring assays for proteins and proteomes

(2009) Paola Picotti et al.   NATURE METHODS